Patent 7300794 was granted and assigned to Supernus Pharmaceuticals, Inc. on November, 2007 by the United States Patent and Trademark Office.
The present invention provides a unique medium for the cultivation of intestinal cell lines. The medium allows for the development of a highly differentiated intestinal epithelial cell monolayer in a much shorter period of time than currently possible without the aid of cell culture substrates.